🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Amicus Therapeutics, Inc.
Market Cap: High
Employees: Medium
Galafold
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for rare diseases, with products including Galafold for Fabry disease and developing therapies for Pompe and CLN3 diseases.
Website
Contact | About | About | Leadership | About | Leadership | About | Contact | Careers | Careers | Careers | Jobs | Careers | Directors | About | Jobs | Careers | About | About | About
Symbol: FOLD
Recent Price: $9.41
Industry: Biotechnology
CEO: Mr. Bradley L. Campbell M.B.A.
Sector: Healthcare
Employees: 500
Address: 3675 Market Street, Philadelphia, PA 19104
Phone: 215 921 7600
Leadership
- Bradley L. Campbell, President and Chief Executive Officer
- Simon Harford, Chief Financial Officer
- David Clark, Chief People Officer
- Jayne C. Gershkowitz, Chief Patient Advocate
- Sébastien Martel, Chief Business Officer
- Ellen S. Rosenberg, Chief Legal Officer
- Jeffrey P. Castelli, Chief Development Officer
- Stephen Arnold, Chief, Head of Global Rare Disease
- Julie Yu, Chief Program Officer
- Pat O’Sullivan, Chief Technical Operations Officer
- Jill Weimer, Chief Science Officer
- Patrik Florencio, Global Chief Compliance and Risk Officer
Last updated: 2024-12-31